Cargando…
Epimutation and cancer: A new carcinogenic mechanism of Lynch syndrome
Epimutation is defined as abnormal transcriptional repression of active genes and/or abnormal activation of usually repressed genes caused by errors in epigenetic gene repression. Epimutation arises in somatic cells and the germline, and constitutional epimutation may also occur. Epimutation is the...
Autores principales: | BANNO, KOUJI, KISU, IORI, YANOKURA, MEGUMI, TSUJI, KOSUKE, MASUDA, KENTA, UEKI, ARISA, KOBAYASHI, YUSUKE, YAMAGAMI, WATARU, NOMURA, HIROYUKI, TOMINAGA, EIICHIRO, SUSUMU, NOBUYUKI, AOKI, DAISUKE |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582986/ https://www.ncbi.nlm.nih.gov/pubmed/22735547 http://dx.doi.org/10.3892/ijo.2012.1528 |
Ejemplares similares
-
Relationship of lower uterine segment cancer with Lynch syndrome: A novel case with an hMLH1 germline mutation
por: MASUDA, KENTA, et al.
Publicado: (2012) -
Association of epigenetic inactivation of the WRN gene with anticancer drug sensitivity in cervical cancer cells
por: MASUDA, KENTA, et al.
Publicado: (2012) -
Endometrial Cancer and Hypermethylation: Regulation of DNA and MicroRNA by Epigenetics
por: Banno, Kouji, et al.
Publicado: (2012) -
Aurora kinase inhibitors: Potential molecular-targeted drugs for gynecologic malignant tumors (Review)
por: Umene, Kiyoko, et al.
Publicado: (2019) -
New candidate therapeutic agents for endometrial cancer: Potential for clinical practice (Review)
por: UMENE, KIYOKO, et al.
Publicado: (2013)